Despite increasing consolidation in the clinical trial industry, there’s enough market share to go around says SOCAR Research CEO Bridget-Anne Kirwan. For SOCAR Research, it’s the company’s strong academic roots in addition to personalized, tailored and innovative services that have helped to make the difference.
To begin, could you please introduce yourself and SOCAR Research?
"There are still a multitude of unmet clinical needs that necessitate research to be done and together with our network of world renowned clinical experts we can make such research happen."
